ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,190Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 814

$977K Total Retail Price of All Prescriptions

Rank: 6 out of 814

619 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 619 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 619 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,011 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $90 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 734 638 1 10
OMEPRAZOLE 656 505 2 1
LISINOPRIL 603 423 3 4
LEVOTHYROXINE SODIUM 584 443 4 3
METOPROLOL TARTRATE 564 449 5 11
SIMVASTATIN 468 277 6 2
HYDROCODONE-ACETAMINOPHEN 383 281 S3 7 6
POTASSIUM CHLORIDE 356 309 8 43
DONEPEZIL HCL 342 305 9 29
AMLODIPINE BESYLATE 307 253 10 5
METFORMIN HCL 264 165 11 8
NAMENDA 248 238 12 48
GABAPENTIN 190 135 13 14
CITALOPRAM HBR 181 154 14 26
RANITIDINE HCL 167 112 15 40
DIOVAN 162 133 16 38
ATENOLOL 161 111 17 18
ISOSORBIDE MONONITRATE ER 148 133 18 81
ATORVASTATIN CALCIUM 136 78 19 12
SPIRIVA 133 102 20 23
TAMSULOSIN HCL 131 109 21 42
SERTRALINE HCL 129 129 22 28
METOPROLOL SUCCINATE 129 112 22 13
OXYBUTYNIN CHLORIDE 128 91 24 127
CARVEDILOL 127 92 25 25
POLYETHYLENE GLYCOL 3350 124 75 26 30
NYSTATIN 123 104 27 142
DIGOXIN 118 113 28 70
ZOLPIDEM TARTRATE 118 52 28 20
HYDROCHLOROTHIAZIDE 118 108 28 9
NYSTOP 115 107 31 250
CLONIDINE HCL 110 69 32 110
ESCITALOPRAM OXALATE 109 92 33 170
TRAZODONE HCL 106 67 34 67
MIRTAZAPINE 103 85 35 102
OXYBUTYNIN CHLORIDE ER 101 63 36 106
GLYBURIDE 101 40 R 36 111
IBUPROFEN 100 52 38 68
RISPERIDONE 98 69 39 86
LANTUS SOLOSTAR 97 54 40 34
LACTULOSE 95 61 41 115
PANTOPRAZOLE SODIUM 94 92 42 54
AMMONIUM LACTATE 93 76 43 109
WARFARIN SODIUM 93 35 43 7
CYMBALTA 89 63 45 59
CIPROFLOXACIN HCL 88 67 46 100
CLOPIDOGREL 88 76 46 35
SPIRONOLACTONE 85 56 48 94
BUMETANIDE 84 70 49 202
COMBIVENT 84 54 49 144
PEN NEEDLE 83 48 51 55
JANTOVEN 81 67 52 82
LANTUS 80 58 53 79
NIASPAN 79 17 54 80
FAMOTIDINE 79 39 54 63
LOSARTAN POTASSIUM 78 78 56 24
CELEBREX 77 42 57 92
VESICARE 77 48 57 103
PRAVASTATIN SODIUM 77 66 57 15
PLAVIX 77 62 57 52
LIPITOR 76 32 61 121
EXELON 74 64 62 91
PREDNISONE 73 55 63 27
FINASTERIDE 73 67 63 116
QUETIAPINE FUMARATE 70 44 65 136
MECLIZINE HCL 68 60 66 231
ADVAIR DISKUS 68 56 66 31
CRESTOR 67 22 68 16
FLUTICASONE PROPIONATE 67 38 68 32
NITROFURANTOIN 64 56 70 208
ARICEPT 63 63 71 180
LEVETIRACETAM 62 11 72 93
PROAIR HFA 61 26 73 39
NEXIUM 60 41 74 17
MELOXICAM 57 57 75 66
CARBIDOPA-LEVODOPA 57 54 75 60
SYMBICORT 57 28 75 84
INSULIN SYRINGE 57 43 75 132
LATANOPROST 56 44 79 323
LIDODERM 55 39 80 172
LOPERAMIDE 54 40 81 332
BACLOFEN 54 17 81 105
QUINAPRIL HCL 51 40 83 130
TRIAMTERENE-HCTZ 50 47 84 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.